Science

AddToAny

Google+ Facebook Twitter Twitter

Medical eponyms pt 3: Guido Fanconi

This is the third of a series of selected short biographies of persons whose names are directly used for diseases, conditions, syndromes or tests familiar to those working in clinical pathology laboratories.
 

The Swiss paediatrician Guido Fanconi (1892-1975) was one of the founders of modern paediatrics whose name is associated with several important syndromes and diseases. He was born in Poschiavo, a small Swiss town, near the northern Italian border, around 100 miles from Milan. In 1911 he commenced studies in medicine and studied at Lausanne, Bern and Zurich, developed a special interest in paediatrics, and qualified in 1919.

He studied paediatrics at the University Children’s hospital of Zurich (Kinderspital) from 1920 and just nine years later he succeeded the noted Swiss paediatrician and academic Emil Feer, as Professor of Paediatrics and Director to establish Kinderspital as one of the leading children’s hospitals in the world. He was astute with recognition of uncommon symptoms as important diseases and gained a grounding of biochemistry under Emil Abderhalden in Halle, Germany.

Please click here to read the full article.

Picture Credit | Alamy

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top